Chemical industry – Page 81
-
Feature
The hunt for innovation
Big pharma companies are embracing a more open and collaborative approach. Nuala Moran discovers who’s working with whom
-
Opinion
Beelzebub Pharma Ltd
Derek Lowe thinks the Devil’s R&D management schemes might be scarily familiar
-
Business
AstraZeneca ends R&D in India
Bangalore site will close with loss of 168 jobs. Some projects will transfer to UK
-
Business
California and Chemtura clash over fire safety
New rules eliminate the need for flame retardants in furniture
-
Business
Ashland cuts jobs in global reshuffle
Speciality chemicals maker will axe 800-1000 positions and relocate 800-1000 more during 2014
-
Business
Jazz spending spree has ups and downs
Aerial sells Jazz rights to sleeping sickness drug but Gentium shareholders put brakes on earlier deal
-
Business
US blocks imports from fourth Ranbaxy plant
FDA bans import of active ingredients from factory in Toansa, India
-
Business
Novartis and DSM trim jobs
Novartis to close US manufacturing site, both companies restructuring Swiss operations
-
News
Croatia's vaccines manufacturer left hanging as it enters administration
Lack of government investment puts national immunology institute in crisis
-
Business
Plug and play redox enzymes
Technology profile: HydRegen is making cofactor-dependent catalysis cleaner
-
Careers
By royal appointment
The Royal Commission for the Exhibition of 1851 brings UK science and industry together through its industrial fellowship scheme. Philip Robinson reports
-
Business
US chemical spill contaminates water supplies
Life beginning to return to normal for locals after being without potable water for several days
-
News
Radical drug rule changes hit buffers in India
Oversight panel concludes government plan will increase bureaucracy
-
Business
Novartis in the spotlight in mis-selling investigations
Crackdown on pharma marketing continues with US and Japanese cases
-
Business
Deadly explosion at Japanese silicon plant
Five killed and several more injured at Mitsubishi Materials site
-
Business
Thermo Fisher to sell three analytical divisions to GE Healthcare
Deal will help the firm complete its ongoing takeover of Life Technologies
-
Opinion
Is there a drug for that?
Derek Lowe ponders whether anything is truly ‘undruggable’ if we look in the right places